Bodal Chemicals Ltd. Reports Q4FY26 Unaudited Financial Results
Bodal Chemicals reported unaudited Q4FY26 results. Consolidated income stood at ₹5,906.03 crore, with profit after tax at ₹320.60 crore. For the full year, consolidated income was ₹20,538.90 crore, and profit after tax was ₹478.28 crore. Standalone figures also showed robust performance.
The announcement of financial results is a routine event for listed companies, but the positive performance indicates a medium impact on investor sentiment and market perception.
The company reported positive financial results with increased income and profits for both the quarter and the full year on both consolidated and standalone bases.
Bodal Chemicals Limited announced its un-audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results on May 21, 2026. The company published these results in The Indian Express (English Edition) and Financial Express (Gujarati Edition) on May 22, 2026.
The consolidated financial results for the quarter ended March 31, 2026, show a total income of ₹5,906.03 crore, a net profit before tax of ₹360.70 crore, and a net profit after tax of ₹320.60 crore. For the financial year ended March 31, 2026, the consolidated total income was ₹20,538.90 crore, with a net profit before tax of ₹544.07 crore and a net profit after tax of ₹478.28 crore.
On a standalone basis for the quarter ended March 31, 2026, the total income was ₹5,789.61 crore, net profit before tax was ₹368.12 crore, and net profit after tax was ₹305.24 crore. For the financial year ended March 31, 2026, the standalone total income was ₹20,132.03 crore, with a net profit before tax of ₹591.67 crore and a net profit after tax of ₹470.44 crore.
What to do with a filing like this
Bodal Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bodal Chemicals Limited. Read the original for the full detail.